Rheumatoid arthritis drug combo trial halted early
NCT ID NCT05942911
First seen Apr 03, 2026 · Last updated May 23, 2026 · Updated 11 times
Summary
This study tested whether a new drug called IHL-675A could safely reduce pain and improve daily function in people with rheumatoid arthritis. The trial planned to enroll 128 adults, but was stopped early with only 20 participants. Participants would have taken the drug twice daily for 24 weeks and reported their pain and function using a standard questionnaire.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AusTrials Wellers Hill
Wellers Hill, Queensland, 4121, Australia
-
AusTrials Westside (Taringa)
Taringa, Queensland, 4068, Australia
-
Captain Sterling Medical Centre
Nedlands, Western Australia, 6009, Australia
-
Coast Joint Care
Maroochydore, Queensland, 4558, Australia
-
Emeritus Research
Sydney, New South Wales, 2019, Australia
-
Emeritus Research Melbourne
Camberwell, Victoria, 3124, Australia
-
Genesis Research Services
Broadmeadow, New South Wales, 2292, Australia
-
Novatrials
Kotara, New South Wales, 2289, Australia
-
Paratus Clinical (Woden Dermatology)
Phillip, Australian Capital Territory, 2606, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
Conditions
Explore the condition pages connected to this study.